Bayer HealthCare Pharmaceuticals, Inc

Title	Investigator	Start	End
Multi-center, open-label, uncontrolled study to assess contraceptive efficacy and safety of Mirena during extended use beyond 5 years in women 18 to 35 years of age including a subgroup evaluation of treatment effect on heavy menstrual bleeding	Darney	3/1/17	2/28/22

Title	Investigator	Start	End
Bayer Service Agreement	Kelly	11/8/12	11/8/15
Bayer 91555 FC Patch-low contraceptive study	Darney	7/8/09	4/30/10

Global Research Projects